Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.
The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.
Links to related guidelines are provided separately:
●Related clinical conditions (see "Society guideline links: Heart failure in adults" and "Society guideline links: Arrhythmias in adults" and "Society guideline links: Atrial fibrillation" and "Society guideline links: Supraventricular arrhythmias" and "Society guideline links: Ventricular arrhythmias" and "Society guideline links: Cardiac valve disease" and "Society guideline links: Cardiomyopathy")
●Related etiologies (see "Society guideline links: Sarcoidosis" and "Society guideline links: Tick-borne infections (Lyme disease, ehrlichiosis, anaplasmosis, babesiosis, and Rocky Mountain spotted fever)" and "Society guideline links: Acute rheumatic fever and rheumatic heart disease" and "Society guideline links: Chagas disease")
Canada
●Canadian Cardiovascular Society (CCS): Consensus conference guidelines on heart failure, update – Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials (2009)
United States
●American College of Radiology (ACR): ACR Appropriateness Criteria on nonischemic myocardial disease with clinical manifestations (ischemic cardiomyopathy already excluded) (2021)
●American Heart Association (AHA): Scientific statement on the recognition and initial management of fulminant myocarditis (2020)
●AHA: Scientific statement on current diagnosis and treatment strategies for specific dilated cardiomyopathies (2016)
●AHA and American College of Cardiology (ACC): Scientific statement on eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities – Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis (2015)
●American College of Cardiology Foundation (ACCF)/ACR/AHA/North American Society for Cardiovascular Imaging (NASCI)/Society for Cardiovascular Magnetic Resonance (SCMR): Expert consensus document on cardiovascular magnetic resonance (2010)
●AHA/ACCF/European Society of Cardiology (ESC): Scientific statement on the role of endomyocardial biopsy in the management of cardiovascular disease (2007)
●AHA: Scientific statement on contemporary definitions and classification of the cardiomyopathies (2006)
Europe
●European Society of Cardiology (ESC): Position statement on the diagnosis and management of myocardial involvement in systemic immune-mediated diseases (2017)
●ESC: Position statement on the current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis (2013)
●American Heart Association (AHA)/American College of Cardiology Foundation (ACCF)/ESC: Scientific statement on the role of endomyocardial biopsy in the management of cardiovascular disease (2007)
Japan
●[In English] Japanese Circulation Society (JCS): Guidelines for diagnosis and treatment of myocarditis, 2009 (published 2011)
●[In Japanese] JCS: Guidelines for diagnosis and treatment of myocarditis (2009)
